Literature DB >> 16461775

Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation.

O M Sieber1, S Segditsas, A L Knudsen, J Zhang, J Luz, A J Rowan, S L Spain, C Thirlwell, K M Howarth, E E M Jaeger, J Robinson, E Volikos, A Silver, G Kelly, S Aretz, I Frayling, P Hutter, M Dunlop, T Guenther, K Neale, R Phillips, K Heinimann, I P M Tomlinson.   

Abstract

BACKGROUND: Attenuated familial adenomatous polyposis (AFAP) is associated with germline mutations in the 5', 3', and exon 9 of the adenomatous polyposis coli (APC) gene. These mutations probably encode a limited amount of functional APC protein. METHODS AND
RESULTS: We found that colonic polyp number varied greatly among AFAP patients but members of the same family tended to have more similar disease severity. 5' Mutants generally had more polyps than other patients. We analysed somatic APC mutations/loss of heterozygosity (LOH) in 235 tumours from 35 patients (16 families) with a variety of AFAP associated germline mutations. In common with two previous studies of individual kindreds, we found biallelic changes ("third hits") in some polyps. We found that the "third hit" probably initiated tumorigenesis. Somatic mutation spectra were similar in 5' and 3' mutant patients, often resembling classical FAP. In exon 9 mutants, in contrast, "third hits" were more common. Most "third hits" left three 20 amino acid repeats (20AARs) on the germline mutant APC allele, with LOH (or proximal somatic mutation) of the wild-type allele; but some polyps had loss of the germline mutant with mutation leaving one 20AAR on the wild-type allele.
CONCLUSIONS: We propose that mutations, such as nt4661insA, that leave three 20AARs are preferentially selected in cis with some AFAP mutations because the residual protein function is near optimal for tumorigenesis. Not all AFAP polyps appear to need "three hits" however. AFAP is phenotypically and genetically heterogeneous. In addition to effects of different germline mutations, modifier genes may be acting on the AFAP phenotype, perhaps influencing the quantity of functional protein produced by the germline mutant allele.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461775      PMCID: PMC1856441          DOI: 10.1136/gut.2005.087106

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.

Authors:  R B van der Luijt; P Meera Khan; H F Vasen; C Breukel; C M Tops; R J Scott; R Fodde
Journal:  Hum Genet       Date:  1996-12       Impact factor: 4.132

2.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC.

Authors:  O M Sieber; K Heinimann; P Gorman; H Lamlum; M Crabtree; C A Simpson; D Davies; K Neale; S V Hodgson; R R Roylance; R K S Phillips; W F Bodmer; I P M Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9.

Authors:  J Young; L A Simms; J Tarish; R Buttenshaw; N Knight; G J Anderson; A Bell; B Leggett
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

5.  Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.

Authors:  P Rozen; Z Samuel; R Shomrat; C Legum
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

6.  Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.

Authors:  D M Eccles; R van der Luijt; C Breukel; H Bullman; D Bunyan; A Fisher; J Barber; C du Boulay; J Primrose; J Burn; R Fodde
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.

Authors:  Michael Crabtree; Oliver M Sieber; Lara Lipton; Shirley V Hodgson; Hanan Lamlum; Hunu J W Thomas; Kay Neale; Robin K S Phillips; Karl Heinimann; Ian P M Tomlinson
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

8.  Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps.

Authors:  L N Spirio; W Samowitz; J Robertson; M Robertson; R W Burt; M Leppert; R White
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

Review 9.  Attenuated familial adenomatous polyposis (AFAP). A review of the literature.

Authors:  Anne Lyster Knudsen; Marie Luise Bisgaard; Steffen Bülow
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

10.  The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.

Authors:  H Lamlum; M Ilyas; A Rowan; S Clark; V Johnson; J Bell; I Frayling; J Efstathiou; K Pack; S Payne; R Roylance; P Gorman; D Sheer; K Neale; R Phillips; I Talbot; W Bodmer; I Tomlinson
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

View more
  24 in total

Review 1.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas.

Authors:  Jin C Kim; In H Ka; Yoo M Lee; Kum H Koo; Hee C Kim; Chang S Yu; Se J Jang; Yong S Kim; Han I Lee; Kang H Lee
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

3.  β-Catenin activation in fundic gland polyps, gastric cancer and colonic polyps in families afflicted by 'gastric adenocarcinoma and proximal polyposis of the stomach' (GAPPS).

Authors:  Lucas A McDuffie; Arvind Sabesan; Michael Allgäeuer; Liqiang Xin; Christopher Koh; Theo Heller; Jeremy L Davis; Mark Raffeld; Markku Miettienen; Martha Quezado; Udo Rudloff
Journal:  J Clin Pathol       Date:  2016-07-12       Impact factor: 3.411

Review 4.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  [Colorectal polyposis syndrome: a guide to diagnosis].

Authors:  A Roessner; D Kuester; T Guenther
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

6.  Expression Profiles in Stage II Colon Cancer According to APC Gene Status.

Authors:  David J Birnbaum; Sophy Laibe; Anthony Ferrari; Arnaud Lagarde; Aurélie J Fabre; Geneviève Monges; Daniel Birnbaum; Sylviane Olschwang
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

Review 7.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

Review 8.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Serrated adenomas.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Marcia Cruz-Correa
Journal:  Curr Gastroenterol Rep       Date:  2009-10

10.  Identification of patients at risk for hereditary colorectal cancer.

Authors:  Nitin Mishra; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.